Schadendorf D - Search Results

1

Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Scherer D, Nagore E, Bermejo JL, Figl A, Botella-Estrada R, Thirumaran RK, Angelini S, Hemminki K, Schadendorf D, Kumar R. Scherer D, et al. Among authors: schadendorf d. Int J Cancer. 2009 Oct 15;125(8):1868-75. doi: 10.1002/ijc.24548. Int J Cancer. 2009. PMID: 19585506

2

Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen.

Sun Y, Song M, Stevanović S, Jankowiak C, Paschen A, Rammensee HG, Schadendorf D. Sun Y, et al. Among authors: schadendorf d. Int J Cancer. 2000 Aug 1;87(3):399-404. doi: 10.1002/1097-0215(20000801)87:3<399::aid-ijc14>3.0.co;2-9. Int J Cancer. 2000. PMID: 10897046

3

Drug-resistance in human melanoma.

Helmbach H, Rossmann E, Kern MA, Schadendorf D. Helmbach H, et al. Among authors: schadendorf d. Int J Cancer. 2001 Sep 1;93(5):617-22. doi: 10.1002/ijc.1378. Int J Cancer. 2001. PMID: 11477569 Review.

4

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

Paschen A, Méndez RM, Jimenez P, Sucker A, Ruiz-Cabello F, Song M, Garrido F, Schadendorf D. Paschen A, et al. Among authors: schadendorf d. Int J Cancer. 2003 Mar 1;103(6):759-67. doi: 10.1002/ijc.10906. Int J Cancer. 2003. PMID: 12516095

5

Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity.

Eichmüller S, Usener D, Thiel D, Schadendorf D. Eichmüller S, et al. Among authors: schadendorf d. Int J Cancer. 2003 Apr 20;104(4):482-7. doi: 10.1002/ijc.10967. Int J Cancer. 2003. PMID: 12584747

6

Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.

Ehlken H, Schadendorf D, Eichmüller S. Ehlken H, et al. Among authors: schadendorf d. Int J Cancer. 2004 Jan 10;108(2):307-13. doi: 10.1002/ijc.11537. Int J Cancer. 2004. PMID: 14639620

7

SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.

Hartmann TB, Bazhin AV, Schadendorf D, Eichmüller SB. Hartmann TB, et al. Among authors: schadendorf d. Int J Cancer. 2005 Mar 10;114(1):88-93. doi: 10.1002/ijc.20762. Int J Cancer. 2005. PMID: 15523688

8

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.

Bloethner S, Chen B, Hemminki K, Müller-Berghaus J, Ugurel S, Schadendorf D, Kumar R. Bloethner S, et al. Among authors: schadendorf d. Carcinogenesis. 2005 Jul;26(7):1224-32. doi: 10.1093/carcin/bgi066. Epub 2005 Mar 10. Carcinogenesis. 2005. PMID: 15760917

9

Lack of clinical efficacy of imatinib in metastatic melanoma.

Ugurel S, Hildenbrand R, Zimpfer A, La Rosée P, Paschka P, Sucker A, Keikavoussi P, Becker JC, Rittgen W, Hochhaus A, Schadendorf D. Ugurel S, et al. Among authors: schadendorf d. Br J Cancer. 2005 Apr 25;92(8):1398-405. doi: 10.1038/sj.bjc.6602529. Br J Cancer. 2005. PMID: 15846297 Free PMC article. Clinical Trial.

10

Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.

Paschen A, Jing W, Drexler I, Klemm M, Song M, Müller-Berghaus J, Nguyen XD, Osen W, Stevanovic S, Sutter G, Schadendorf D. Paschen A, et al. Among authors: schadendorf d. Int J Cancer. 2005 Oct 10;116(6):944-8. doi: 10.1002/ijc.21132. Int J Cancer. 2005. PMID: 15856458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,107 results

Search Page

Filters